Immuno-Biological Laboratories Co., Ltd.

TSE:4570 Stock Report

Market Cap: JP¥4.2b

Immuno-Biological Laboratories Management

Management criteria checks 2/4

Immuno-Biological Laboratories' CEO is Tsutomu Seito, appointed in Sep 1982, has a tenure of 42.25 years. directly owns 12.07% of the company’s shares, worth ¥507.91M. The average tenure of the management team and the board of directors is 16.5 years and 12 years respectively.

Key information

Tsutomu Seito

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure42.3yrs
CEO ownership12.1%
Management average tenure16.5yrs
Board average tenure12yrs

Recent management updates

Recent updates

There May Be Underlying Issues With The Quality Of Immuno-Biological Laboratories' (TSE:4570) Earnings

Nov 20
There May Be Underlying Issues With The Quality Of Immuno-Biological Laboratories' (TSE:4570) Earnings

Immuno-Biological Laboratories (TSE:4570) Seems To Use Debt Rather Sparingly

Aug 03
Immuno-Biological Laboratories (TSE:4570) Seems To Use Debt Rather Sparingly

Investors Shouldn't Be Too Comfortable With Immuno-Biological Laboratories' (TSE:4570) Earnings

May 22
Investors Shouldn't Be Too Comfortable With Immuno-Biological Laboratories' (TSE:4570) Earnings

We Think Immuno-Biological Laboratories (TSE:4570) Can Manage Its Debt With Ease

Feb 29
We Think Immuno-Biological Laboratories (TSE:4570) Can Manage Its Debt With Ease

Is Immuno-Biological Laboratories (TYO:4570) Using Debt In A Risky Way?

Feb 09
Is Immuno-Biological Laboratories (TYO:4570) Using Debt In A Risky Way?

CEO

Tsutomu Seito (80 yo)

42.3yrs

Tenure

Tsutomu Seito has been the President and Representative Director of Immuno-Biological Laboratories Co., Ltd. since September 1982 and also serves as its Chairman. Tsutomu Seito served as General Manager of...


Leadership Team

NamePositionTenureCompensationOwnership
Tsutomu Seito
Chairman & President42.3yrsno data12.07%
¥ 507.9m
Masato Nakagawa
MD, COO3.5yrsno data0.11%
¥ 4.6m
Shoko Onodera
GM of Human Resources16.5yrsno data0.54%
¥ 22.6m

16.5yrs

Average Tenure

63yo

Average Age

Experienced Management: 4570's management team is seasoned and experienced (16.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Tsutomu Seito
Chairman & President42.3yrsno data12.07%
¥ 507.9m
Masato Nakagawa
MD, COO16.5yrsno data0.11%
¥ 4.6m
Shoko Onodera
GM of Human Resources23.5yrsno data0.54%
¥ 22.6m
Kenji Fukunaga
Independent Outside Director13.5yrsno datano data
Takeshi Tayama
External Auditor10.5yrsno datano data
Sadahiro Okazumi
Corporate Auditor6.5yrsno datano data
Ikkei Kojima
Independent External Director5.5yrsno datano data
Nobuaki Yoshida
Auditor2.5yrsno datano data

12.0yrs

Average Tenure

59.5yo

Average Age

Experienced Board: 4570's board of directors are seasoned and experienced ( 12 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 13:30
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Immuno-Biological Laboratories Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution